Veru Dividend

Dividend criteria checks 0/6

Veru does not currently pay a dividend.

Key information

0%

Dividend yield

0%

Payout ratio

Industry average yield2.8%
Next dividend pay daten/a
Ex dividend daten/a
Dividend per sharen/a
Earnings per share-US$0.43
Dividend yield forecast in 3Yn/a

Recent dividend updates

No updates

Recent updates

The Price Is Right For Veru Inc. (NASDAQ:VERU) Even After Diving 52%

Jan 09
The Price Is Right For Veru Inc. (NASDAQ:VERU) Even After Diving 52%

Revenue Downgrade: Here's What Analysts Forecast For Veru Inc. (NASDAQ:VERU)

Aug 16
Revenue Downgrade: Here's What Analysts Forecast For Veru Inc. (NASDAQ:VERU)

Veru Inc.'s (NASDAQ:VERU) Stock Retreats 38% But Revenues Haven't Escaped The Attention Of Investors

Apr 17
Veru Inc.'s (NASDAQ:VERU) Stock Retreats 38% But Revenues Haven't Escaped The Attention Of Investors

Veru Inc.'s (NASDAQ:VERU) Intrinsic Value Is Potentially 99% Above Its Share Price

Feb 14
Veru Inc.'s (NASDAQ:VERU) Intrinsic Value Is Potentially 99% Above Its Share Price

Veru (NASDAQ:VERU) Has Debt But No Earnings; Should You Worry?

Jan 13
Veru (NASDAQ:VERU) Has Debt But No Earnings; Should You Worry?

Analysts Just Shaved Their Veru Inc. (NASDAQ:VERU) Forecasts Dramatically

Nov 13
Analysts Just Shaved Their Veru Inc. (NASDAQ:VERU) Forecasts Dramatically

Veru Inc.: Safer Bet Is To Wait For The AdComm Verdict

Oct 17

Is Veru (NASDAQ:VERU) Weighed On By Its Debt Load?

Sep 26
Is Veru (NASDAQ:VERU) Weighed On By Its Debt Load?

Veru FDA AdCom meeting for COVID-19 therapy postponed

Sep 19

Veru: A Good Combination Of A Stable Business And Growth Opportunities

Sep 13

Veru surges 11% as FDA sets AdCom meeting to review COVID-19 therapy

Sep 07

Veru sheds 13% to end rally as director sells shares

Aug 18

Veru Q3 2022 Earnings Preview

Aug 10

Veru updated analysis on COVID treatment sabizabulin will lead to EUA - Oppenheimer

Aug 03

Veru eligible for expedited review in U.K. for COVID-19 therapy

Jul 25

Veru: The Signs Seem To Point To An EUA For Sabizabulin

Jul 13

Veru phase 3 results of sabizabulin for COVID-19 published in NEJM

Jul 06

Veru: On Right Track For FDA EUA Submission

May 27

Is Veru (NASDAQ:VERU) Using Debt Sensibly?

May 25
Is Veru (NASDAQ:VERU) Using Debt Sensibly?

Veru: Where Big Pharma Failed To Tread

May 17

Veru: The Russian/Ukraine Conflict May Pose Challenges

Mar 03

Stability and Growth of Payments

Fetching dividends data

Stable Dividend: Insufficient data to determine if VERU's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if VERU's dividend payments have been increasing.


Dividend Yield vs Market

Veru Dividend Yield vs Market
How does VERU dividend yield compare to the market?
SegmentDividend Yield
Company (VERU)0%
Market Bottom 25% (US)1.6%
Market Top 25% (US)4.9%
Industry Average (Personal Products)2.8%
Analyst forecast in 3 Years (VERU)n/a

Notable Dividend: Unable to evaluate VERU's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate VERU's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Earnings Payout to Shareholders

Earnings Coverage: VERU is not paying a notable dividend for the US market.


Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as VERU has not reported any payouts.


Discover strong dividend paying companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.